SAN DIEGO, March 1, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) announced today that the European Patent Office (“EPO”) will grant a patent for the company’s MycoVa™ product for treating onychomycosis (commonly referred to as nail fungus).
